Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes

References

• Berry, M., Fielding, B. C., & Gamieldien, J. (2015). Potential broad spectrum inhibitors of the Coronavirus 3CLpro: A virtual screening and structure-based drug design study. Viruses, 7(12), 6642–6660. https://doi.org/10.3390/v7122963
   PubMed Web of Science ®Google Scholar
• Bhattacharya, D., Nowotny, J., Cao, R., & Cheng, J. (2016). 3Drefine: An interactive web server for efficient protein structure refinement. Nucleic Acids Research, 44(W1), W406–W409. https://doi.org/10.1093/nar/gkw336
   PubMed Web of Science ®Google Scholar
• Boonstra, S., Onck, P. R., & Van Der Giessen, E. (2016). CHARMM TIP3P Water Model Suppresses Peptide Folding by Solvating the Unfolded State. The Journal of Physical Chemistry B, 120(15), 3692–3698. https://doi.org/10.1021/acs.jpcb.6b01316
   PubMed Web of Science ®Google Scholar
• Böttcher, E., Matrosovich, T., Beyerle, M., Klenk, H.-D., Garten, W., & Matrosovich, M. (2006). Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. Journal of Virology, 80(19), 9896–9898. https://doi.org/10.1128/JVI.01118-06
   PubMed Web of Science ®Google Scholar
• Clark, B. G., Jue, S. G., Dawson, G. W., & Ward, A. (1986). Loprazolam: A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in insomnia. Drugs, 31(6), 500–516. doi.org/
   PubMed Web of Science ®Google Scholar
• Clark, J. W. (2006). Rubitecan. Expert Opinion on Investigational Drugs, 15(1), 71–79. https://doi.org/10.1517/13543784.15.1.71
   PubMed Web of Science ®Google Scholar
• Colovos, C., & Yeates, T. O. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science, 2(9), 1511–1519. https://doi.org/10.1002/pro.5560020916
   PubMed Web of Science ®Google Scholar
• Worldometer. (2020). Coronavirus Update (Live): 1,790,824 cases and 109,662 Deaths from COVID-19 virus pandemic. https://www.worldometers.info/coronavirus/
   Google Scholar
• Corponi, F., Fabbri, C., Bitter, I., Montgomery, S., Vieta, E., Kasper, S., Pallanti, S., & Serretti, A. (2019). Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone. European Neuropsychopharmacology, 29(9), 971–985. https://doi.org/10.1016/j.euroneuro.2019.06.008
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 1–13. (October 2016), https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Gierer, S., Bertram, S., Kaup, F., Wrensch, F., Heurich, A., Kramer-Kuhl, A., Welsch, K., Winkler, M., Meyer, B., Drosten, C., Dittmer, U., von Hahn, T., Simmons, G., Hofmann, H., & Pohlmann, S. (2013). The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. Journal of Virology, 87(10), 5502–5511. https://doi.org/10.1128/JVI.00128-13
   PubMed Web of Science ®Google Scholar
• Hoffmann, M., Kleine-Weber, H., Krüger, N., Müller, M., Drosten, C., & Pöhlmann, S. (2020). The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. Cell, 181, 271–280. https://doi.org/10.1101/2020.01.31.929042
   Google Scholar
• Iwata-Yoshikawa, N., Okamura, T., Shimizu, Y., Hasegawa, H., Takeda, M., & Nagata, N. (2019). TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection. Journal of Virology, 93(6), e01815–18. https://doi.org/10.1128/JVI.01815-18
   PubMed Web of Science ®Google Scholar
• Jo, S., Kim, T., Iyer, V. G., & Im, W. (2008). CHARMM-GUI: A web-based graphical user interface for CHARMM. Journal of Computational Chemistry, 29(11), 1859–1865. https://doi.org/10.1002/jcc.20945
   PubMed Web of Science ®Google Scholar
• Khan, R. J., Jha, R., Amera, G. M., Jain, M., Singh, E., Pathak, A., & Singh, A. (2020). Targeting novel coronavirus 2019: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2’-O-ribose methyltransferase. Journal of Biomolecular Structure and Dynamics, (2), 1–40. https://doi.org/10.26434/chemrxiv.11888730
   Google Scholar
• Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2020). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/10.1080/07391102.2020.1751298
   Web of Science ®Google Scholar
• Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., Lee, M., Lee, T., Duan, Y., Wang, W., Donini, O., Cieplak, P., Srinivasan, J., Case, D. A., & Cheatham, T. E. (2000). Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Accounts of Chemical Research, 33(12), 889–897. https://doi.org/10.1021/ar000033j
   PubMed Web of Science ®Google Scholar
• Kyrieleis, O. J. P., Huber, R., Ong, E., Oehler, R., Hunter, M., Madison, E. L., & Jacob, U. (2007). Crystal structure of the catalytic domain of DESC1, a new member of the type II transmembrane serine proteinase family. FEBS Journal, 274(8), 2148–2160. https://doi.org/10.1111/j.1742-4658.2007.05756.x
   PubMed Web of Science ®Google Scholar
• Laporte, M., & Naesens, L. (2017). Airway proteases: An emerging drug target for influenza and other respiratory virus infections. Current Opinion in Virology, 24, 16–24. https://doi.org/10.1016/j.coviro.2017.03.018
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291. https://doi.org/10.1107/S0021889892009944
   Web of Science ®Google Scholar
• Lipinski, C. A. (2004). Lead- and drug-like compounds: The rule-of-five revolution. Drug Discovery Today: Technologies, 1(4), 337–341. https://doi.org/10.1016/j.ddtec.2004.11.007
   PubMedGoogle Scholar
• Liu, H., & Hou, T. (2016). CaFE: A tool for binding affinity prediction using end-point free energy methods. Bioinformatics, 32(14), 2216–2218. https://doi.org/10.1093/bioinformatics/btw215
   PubMed Web of Science ®Google Scholar
• Matsuyama, S., Nagata, N., Shirato, K., Kawase, M., Takeda, M., & Taguchi, F. (2010). Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. Journal of Virology, 84(24), 12658–12664. https://doi.org/10.1128/JVI.01542-10
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Ruth, H., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Nicholls, A., & Honig, B. (1991). A rapid finite difference algorithm, utilizing successive over‐relaxation to solve the Poisson–Boltzmann equation. Journal of Computational Chemistry, 12(4), 435–445. https://doi.org/10.1002/jcc.540120405
   Web of Science ®Google Scholar
• Oany, A. R., Emran, A., Al., & Jyoti, T. P. (2014). Design of an epitope-based peptide vaccine against spike protein of human coronavirus: An in silico approach. Drug Design, Development and Therapy, 8, 1139–1149. https://doi.org/10.2147/DDDT.S67861
   PubMed Web of Science ®Google Scholar
• Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26(16), 1781–1802. https://doi.org/10.1002/jcc.20289
   PubMed Web of Science ®Google Scholar
• Sarma, P., Sekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., & Medhi, B. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure & Dynamics, 1–11. https://doi.org/10.1080/07391102.2020.1753580
   PubMed Web of Science ®Google Scholar
• Shulla, A., Heald-Sargent, T., Subramanya, G., Zhao, J., Perlman, S., & Gallagher, T. (2011). A Transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. Journal of Virology, 85(2), 873–882. https://doi.org/10.1128/JVI.02062-10
   PubMed Web of Science ®Google Scholar
• Sielaff, F., Böttcher-Friebertshäuser, E., Meyer, D., Saupe, S. M., Volk, I. M., Garten, W., & Steinmetzer, T. (2011). Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT. Bioorganic & Medicinal Chemistry Letters, 21(16), 4860–4864. https://doi.org/10.1016/j.bmcl.2011.06.033
   PubMed Web of Science ®Google Scholar
• Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014). Computational methods in drug discovery. Pharmacological Reviews, 66(1), 334–395. https://doi.org/10.1124/pr.112.007336
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2009). Software news and update AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), NA–461. https://doi.org/10.1002/jcc.21334
   Web of Science ®Google Scholar
• Vyas, V. K., Ukawala, R. D., Ghate, M., & Chintha, C. (2012). Homology modeling a fast tool for drug discovery: Current perspectives. Indian Journal of Pharmaceutical Sciences, 74(1), 1–17. https://doi.org/10.4103/0250-474X.102537
   PubMed Web of Science ®Google Scholar
• Webb, B., & Sali, A. (2016). Comparative protein structure modeling using MODELLER. Current Protocols in Bioinformatics, 54(1), 5.6.1–5.6.37. https://doi.org/10.1002/cpbi.3
   PubMedGoogle Scholar
• Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35(Web Server), W407–410. https://doi.org/10.1093/nar/gkm290
   PubMed Web of Science ®Google Scholar
• Xiang, Z. (2006). Advances in homology protein structure modeling. Current Protein & Peptide Science, 7(3), 217–227. https://doi.org/10.2174/138920306777452312
   PubMed Web of Science ®Google Scholar
• Yang, H., Lou, C., Sun, L., Li, J., Cai, Y., Wang, Z., Li, W., Liu, G., & Tang, Y. (2019). AdmetSAR 2.0: Web-service for prediction and optimization of chemical ADMET properties. Bioinformatics, 35(6), 1067–1069. https://doi.org/10.1093/bioinformatics/bty707
   PubMed Web of Science ®Google Scholar
• Zhou, J., Fang, L., Yang, Z., Xu, S., Lv, M., Sun, Z., Chen, J., Wang, D., Gao, J., & Xiao, S. (2019). Identification of novel proteolytically inactive mutations in coronavirus 3C-like protease using a combined approach. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 33(12), 14575–14587. https://doi.org/10.1096/fj.201901624RR
   PubMed Web of Science ®Google Scholar